Company news

Cosmos Health Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Cosmos Health Announces Pricing of $7.5 Million Upsized Public Offering

October 17, 2022

Cosmos Health Enters into a Warrant Exchange Agreement, Replacing Structured Warrants with Plain-Vanilla Warrants

October 3, 2022

Cosmos Health Enters into Letter of Intent for the Acquisition of ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.

September 27, 2022

Cosmos Health Signs an Agreement with Virax Biolabs to Distribute Monkeypox Virus Real-Time PCR Detections Kits in Europe

September 21, 2022

Cosmos Health to Launch Sky Premium Life Nutritional Supplement Products in Germany and Austria via Amazon and Ebay

September 14, 2022

Cosmos Health Launches First Sky Premium Life Nutritional Supplement Products on Amazon in the United States

August 24, 2022

Cosmos Health Reports 202.42 % Increase in Adjusted EBITDA and Positive Operating Income for the First Half of 2022

August 21, 2022

Cosmos Holdings Announces Name Change to Cosmos Health, Reflecting Company's Evolution into an Innovative Global Healthcare Group, Driven by One Purpose: Improving People's Lives

July 28, 2022

Cosmos Holdings Appoints Dr. Manfred Ziegler to its Advisory Board

July 21, 2022

Cosmos Holdings Announces Agreement to Acquire Cana Laboratories, a Legacy European Pharmaceutical Company Established in 1928; Vertically Integrating its Manufacturing and R&D Capabilities and Expanding its Product Pipeline with New Brands

July 19, 2022

Cosmos Holdings Subsidiary Granted Full Membership in PAGB, A UK-based Consumer Healthcare Association

July 11, 2022

Cosmos Holdings Appoints Dr. Panagiotis Zoumpoulakis to its Advisory Board

July 7, 2022

Cosmos Holdings to Acquire LIFE NLB Portfolio of Bone Health Products that Target the Gastrointestinal Microbiome

July 5, 2022

Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders

June 29, 2022

Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon in the United States

June 1, 2022

Cosmos Holdings Reports 12.5% Increase in Revenue, 88.9% Increase in Gross Profit and Achieves Profitability for the First Quarter of 2022

May 17, 2022

Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon Canada

May 4, 2022

Cosmos Holdings Appoints Finance Veteran Dr. Anastasios Aslidis to the Board of Directors and as a Member of the Board's Audit Committee

May 2, 2022

Cosmos Holdings Reports Continued Revenue Growth and Achieves $3.3 Million of Adjusted EBITDA for the Fiscal Year 2021

April 18, 2022

Cosmos Holdings Launches Mediterranation, a New Premium Nutritional Supplements Line

April 11, 2022

Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon Singapore

April 4, 2022

Cosmos Holdings Launches Proprietary Sky Premium Life Brainlit Supplement for Brain Health

March 30, 2022

Cosmos Holdings Launches Proprietary Sky Premium Life Prostatium Supplement for Prostate Health

March 27, 2022

Cosmos Holdings to Ring Closing Bell Today to Celebrate Milestone NASDAQ Listing

March 10, 2022

Cosmos Holdings Announces Closing of $6 Million Private Placement of Convertible Preferred Stock and Start of Trading on the Nasdaq

February 27, 2022

Cosmos Holdings Announces Shareholder Approval of Private Offering

December 19, 2021

Cosmos Holdings Achieves Positive Adjusted Net Income and Positive Adjusted EBITDA for the Third Quarter of 2021

November 15, 2021

Cosmos Holdings Announces Installation of State-of-the-Art Automated Fulfillment System to Maximize the Productivity of CosmoFarm’s Pharmaceutical Logistic Center in Athens, Greece

November 14, 2021

Cosmos Holdings Secures Approximately $5.5 Million Investment from Ault Global Holdings

September 20, 2021

Cosmos Holdings Announces Voluntary Conversion of Debt to Equity by the Company’s Senior Lender, Further Enhancing the Balance Sheet

August 17, 2021

Cosmos Holdings Reports 15.8% Year-Over-Year Growth and 27.8% Sequential Increase in Revenue for the Second Quarter of 2021

August 16, 2021

Cosmos Holdings CEO Greg Siokas Converts an Additional $1.0 Million of Debt into Common Stock at $6.00 Per Share

July 15, 2021

Cosmos Holdings Signs Exclusive Distribution Agreement with Mediprovita GbR for Launch of Sky Premium Life Products in Germany and Austria

July 7, 2021

Cosmos Holdings Appoints Finance Veteran Alexi Papaconstantinou to its Advisory Board

June 30, 2021

Cosmos Holdings CEO Greg Siokas Converts $3.0 Million of Debt into Common Stock at $6.00 Per Share

June 27, 2021

Cosmos Holdings Provides First Quarter 2021 Business Update; Reports 89% Year-Over-Year and 60% Sequential Increase in Nutraceutical Business

May 17, 2021

Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon UK

April 26, 2021

Cosmos Holdings Reports Revenue Growth of 40% to a Record $55.4 Million and Achieves Profitability for 2020

April 15, 2021

Cosmos Holdings Launches Mosept-Oral Antiseptic Spray Designed to be Effective Against Bacteria and Certain Viral Pathogens

April 7, 2021

Cosmos Holdings Launches Osteodome in EU

February 10, 2021

Cosmos Holdings Launches New Proprietary Enhanced Dietary Supplement

January 10, 2021

Cosmos Holdings Announces December 4th Virtual Bell Ringing to Open Trading on the OTCQX Best Market

December 3, 2020

Cosmos Holdings, Inc. Announces Q2 2020 Financial and Operating Results

August 17, 2020

Cosmos Holdings, Inc. Announces Year End 2019 & Q1 2020 Financial and Operating Results

May 19, 2020

Cosmos Holdings, inc. signs for exclusive representation agreement of covid-19 diagnostic detection kit for germany, england, Greece & cyprus

April 7, 2020

← Newer news releases

Decks